Why the global pharma industry will adopt digital health tools in coming five years
(c)iStock.com/Kwangmoozzaa
A recently published research paper by healthcare technology provider Validic states that the global pharma and biotech will increasingly turn to digital health tools over the next five years to better collect, analyse and act on patient-generated health data (PGHD). This growth is attributed to increased pressures to reduce trials costs, streamline processes, demonstrate real world-efficacy, address medication adherence and improve treatments for chronic diseases.
The survey...